Who is recommended to receive COVID-19 vaccines?

All people age 6 months and older in the United States are recommended to receive one or more doses of an age-appropriate 2024–2025 Formula COVID-19 vaccination. Product options include two mRNA vaccines (Pfizer-BioNTech, Moderna) and one protein subunit vaccine (Novavax). Schedules vary by age and immunocompromised status.